Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Vick–Fragoso R et al. – Treatment with sequential iv/po moxifloxacin monotherapy once daily is clinically comparable to that with iv/po amoxicillin/clavulanate three times daily in the management of cSSSIs. Moxifloxacin’s simple dose regimen offers an advantage over amoxicillin/clavulanate and represents a valuable addition to current antibiotic regimens used in the treatment of cSSSIs.

Related Articles

Clinical Importance of Purulence in Methicillin-Resistant Staphylococcus aureus Skin and Soft Tissue Infections
Journal of the American Board of Family Medicine, 11/09/09    Relevance Score: 80%

Treatment of Complicated Skin and Soft Tissue Infections
Surgical Infections, 11/02/09    Relevance Score: 80%

Clinical evaluation of the QuantiFERON-TB Gold test in patients with non-tuberculous mycobacterial disease
The International Journal of Tuberculosis and Lung Disease, 10/30/09    Relevance Score: 80%

Candida Skin Testing Is A Poor Adjunct To Tuberculin Skin Testing in International Adoptees
The Pediatric Infectious Disease Journal, 10/14/09    Relevance Score: 80%

Severe skin and soft tissue infections
Intensivmedizin und Notfallmedizin, 10/02/09    Relevance Score: 80%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address